In vitro and in vivo evaluation of an oscillometric device for monitoring blood pressure in dialysis patients.
BACKGROUND
Nowadays, an increasing number of dialysis machines lodge a blood pressure (BP) measuring device, whose accuracy has a clear implication for the patients' clinical management.


METHODS
An automated oscillometric sphygmomanometer (HD-BPM by Gambro Dasco) used during haemodialysis was submitted to both in vitro and in vivo tests, in order to evaluate some modifications aimed at improving measurement accuracy and consistency. The results were compared with those obtained by another oscillometric monitor (BX-100 by Colin). Three steps of evaluation were followed. First, the maintenance of the overall accuracy requirements prescribed by ANSI/AAMI SP-10 standard was verified. Then, an in vitro validation was carried out by using a test simulator. Finally, during a multi-centre field trial, 392 BP measurement sessions on 53 dialysis patients were collected. Every session consisted of two consecutive intra-dialysis measurements by the oscillometric monitors, each one performed simultaneously to an auscultatory measurement. A comparison with the intra-arterial method was performed as well.


RESULTS
When compared with an in vivo data set previously collected, the HD-BPM accuracy complied with required limits. Second, the internal repeatability with respect to the simulator was satisfactory (SD of the differences between device and simulator readings: HD-BPM: systolic = 5.7, diastolic = 4.2; BX-100: systolic = 4.2, diastolic = 5.5 mmHg). Moreover, the comparison between oscillometric and auscultatory methods during in vivo trial gave similar results for the two monitors, even if systolic pressure SD exceeds the limit recommended by ANSI/AAMI SP-10 (mean value of the differences +/- SD: HD-BPM: systolic = 0.5 +/- 9.0, diastolic = 1.5 +/- 6.9; BX-100: systolic = 3.1 +/- 8.2, diastolic = -2.0 +/- 7.6 mmHg).


CONCLUSIONS
These data underline the importance of performing accuracy evaluations for BP monitors in the conditions where they normally work, by using well-accepted protocols.
Lodi
Carlo Alberto
CA
R&D, Gambro Dasco S.p.A., Via Modenese, 66, I--41036 Medolla (MO), Italy. carlo.lodi@gambro.com
Estridge
Charles
C
Ghidini
Carlo
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000175:diagnosis; D001794:Blood Pressure; D001795:Blood Pressure Determination / Q000379:methods*; D015924:Blood Pressure Monitors; D002648:Child; D004867:Equipment Design; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008628:Mercury; D008875:Middle Aged; D009991:Oscillometry / Q000295:instrumentation / Q000379:methods*; D006435:Renal Dialysis / Q000295:instrumentation / Q000379:methods*; D015203:Reproducibility of Results; D019722:Sphygmomanometers
D008628:Mercury